MLL-PTD as a marker for minimal residual disease studies: quantification counts.
Medical Dept., Laboratory for Molecular Diagnostics, University Hospital Carl Gustav Carus, University of Techniques Dresden, Fetscherstr 74, 01307 Dresden, Germany. thiede@mk1.med.tu-dresden.de
Christian
C
Thiede
D014408:Biomarkers, Tumor; D020440:Gene Duplication; D011495:Histone-Lysine N-Methyltransferase; D006801:Humans; D007621:Karyotyping; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis* / Q000235:genetics* / Q000628:therapy; D051788:Myeloid-Lymphoid Leukemia Protein / Q000096:biosynthesis / Q000235:genetics*; D011379:Prognosis; D012008:Recurrence; D020133:Reverse Transcriptase Polymerase Chain Reaction; D018570:Risk Assessment
D014408:Biomarkers, Tumor; C497422:KMT2A protein, human; D051788:Myeloid-Lymphoid Leukemia Protein; D011495:Histone-Lysine N-Methyltransferase